Professor Ding Wexin has been invited to give a seminar in the School of Chinese Medicine on 28 July, 2014. The title of his presentation was “The double-edged Sword of Autophagy and Nrf2 in Cancer”.

Ding Wexin is from Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, USA. His research areas as follows: (1) Autophagy and Apoptosis in liver injury and cancer therapy; (2) Redox Signaling and Mitochondrial damage; (3) Autophagy and Apoptosis in liver injury and cancer therapy; (4) Redox Signaling and Mitochondrial damage; and (5) Mitophagy. He published numerous papers in high-rank journals which include Journal of Hepatology, Hepatology, Autophagy, Experimental Biology and Medicine, et al. 

Prof. Li Min (left) with Prof. Ding Winxin (centre) at SCM of HKBU.

Prof. Li Min and her team members with Prof. Ding Winxin at SCM of HKBU.